Sign in

CIK 0001783036 · Non-accelerated filer<br>Emerging growth company

NewcelX Ltd.

Sign in to watch
Ticker
NCEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
other
Phone
41-41-618-80-00
Business address
THE CIRCLE 6, 8058, ZURICH, Switzerland
Former names
NLS Pharmaceutics Ltd.
  1. EFFECT Other Notice of Effectiveness
  2. UPLOAD Other SEC-generated Letter
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. D Other Notice of Sales of Unregistered Securities
  5. F-3 Offering F-3
  6. EFFECT Other Notice of Effectiveness
  7. POS AM Other Post-effective Amendment for Registration Statement
  8. SCHEDULE 13D Stake Beneficial Ownership Report
  9. 6-K Event Report of Foreign Issuer
  10. 20-F Report Annual and Transition Report of Foreign Private Issuers
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 6-K Event Report of Foreign Issuer
  14. 6-K Event Report of Foreign Issuer
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 2 of 21 · 419 filings